EXC vs UPB · P/E 17, rev $24.26B vs rev $2.9M
Exelon Corporation (EXC) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. UPB currently screens at market cap $407.3M.
Not investment advice. Open the EXC and UPB stock pages for the full models.
Not investment advice.